{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:02:59Z","timestamp":1790611379828,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejim.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T20:10:23Z","timestamp":1724098223000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The clinical relevance of the reversal of coronary atherosclerotic plaque"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-1235","authenticated-orcid":false,"given":"Arturo","family":"Cesaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Acerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-830X","authenticated-orcid":false,"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ejim.2024.08.010_bib0001","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7855","key":"10.1016\/j.ejim.2024.08.010_bib0002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ejim.2024.08.010_bib0003","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehac686","article-title":"Translational opportunities of single-cell biology in atherosclerosis","volume":"44","author":"de Winther","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2024.08.010_bib0004","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/ATVBAHA.106.137851","article-title":"Topological determinants and consequences of adventitial responses to arterial wall injury","volume":"27","author":"Michel","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.ejim.2024.08.010_bib0005","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.ejim.2024.08.010_bib0006","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2024.08.010_bib0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2021.09.008","article-title":"Air pollution and coronary plaque vulnerability and instability","volume":"15","author":"Montone","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"17","key":"10.1016\/j.ejim.2024.08.010_bib0008","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2018.07.099","article-title":"Air pollution and cardiovascular disease","volume":"72","author":"Rajagopalan","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2024.08.010_bib0009","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.3390\/ijms24109087","article-title":"Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship","volume":"24","author":"Nesci","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.ejim.2024.08.010_bib0011","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease","volume":"67","author":"Libby","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2024.08.010_bib0012","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.120.315936","article-title":"Modifiable cardiovascular risk, hematopoiesis, and innate immunity","volume":"126","author":"Schloss","year":"2020","journal-title":"Circ Res"},{"issue":"41","key":"10.1016\/j.ejim.2024.08.010_bib0013","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/eht351","article-title":"Endothelial dysfunction over the course of coronary artery disease","volume":"34","author":"Gutierrez","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0014","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2018.12.075","article-title":"Vascular inflammation in subclinical atherosclerosis detected by hybrid PET\/MRI","volume":"73","author":"Fern\u00e1ndez-Friera","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ejim.2024.08.010_bib0016","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.08.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvab303","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0019","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.79.4.733","article-title":"Circadian variation and triggers of onset of acute cardiovascular disease","volume":"79","author":"Muller","year":"1989","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heart.83.3.361","article-title":"Coronary disease: the pathophysiology of acute coronary syndromes","volume":"83","author":"Davies","year":"2000","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ejim.2024.08.010_bib0021","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S0002-8703(99)70267-X","article-title":"Stable versus unstable atherosclerosis: clinical aspects","volume":"138","author":"Falk","year":"1999","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/hrt.82.3.269","article-title":"Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction","volume":"82","author":"Arbustini","year":"1999","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.ejim.2024.08.010_bib0023","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"New England J Med"},{"issue":"11","key":"10.1016\/j.ejim.2024.08.010_bib0024","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurheartj\/ehz081","article-title":"Once more unto the breach: endothelial permeability and atherogenesis","volume":"40","author":"Libby","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2024.08.010_bib0025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/eurheartj\/ehy822","article-title":"Haemodynamic stress-induced breaches of the arterial intima trigger inflammation and drive atherogenesis","volume":"40","author":"Franck","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ejim.2024.08.010_bib0026","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.ejim.2024.08.010_bib0027","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/hc0802.104327","article-title":"Relationship between coronary artery remodeling and plaque vulnerability","volume":"105","author":"Varnava","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0735-1097(98)00304-0","article-title":"Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox","volume":"32","author":"Pasterkamp","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0029","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejim.2024.08.010_bib0030","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2018.10.093","article-title":"Healed culprit plaques in patients with acute coronary syndromes","volume":"73","author":"Fracassi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2024.08.010_bib0031","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMra2000317","article-title":"Atherosclerotic plaque healing","volume":"383","author":"Vergallo","year":"2020","journal-title":"New England J Med"},{"issue":"17","key":"10.1016\/j.ejim.2024.08.010_bib0032","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM198610233151702","article-title":"Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries","volume":"315","author":"Ludmer","year":"1986","journal-title":"New England J Med"},{"issue":"22","key":"10.1016\/j.ejim.2024.08.010_bib0033","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"New England J Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0034","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.CIR.103.4.604","article-title":"Intravascular ultrasound: novel pathophysiological insights and current clinical applications","volume":"103","author":"Nissen","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2024.08.010_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12410-013-9224-2","article-title":"Intracoronary near-infrared spectroscopy (nirs) imaging for detection of lipid content of coronary plaques: current experience and future perspectives","volume":"6","author":"Jaguszewski","year":"2013","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"10","key":"10.1016\/j.ejim.2024.08.010_bib0036","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2024.08.010_bib0037","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2022.11.045","article-title":"Intravascular imaging during percutaneous coronary intervention: JACC State-of-the-Art review","volume":"81","author":"Truesdell","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2024.08.010_bib0038","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3390\/jcm13113096","article-title":"Role of lipid-lowering and anti-inflammatory therapies on plaque stabilization","volume":"13","author":"Bryniarski","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2024.08.010_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5590093","article-title":"Reduction of lipid-core burden index in nonculprit lesions at follow-up after ST-elevation myocardial infarction: a randomized study of bioresorbable vascular scaffold versus optimal medical therapy","volume":"2021","author":"Kefer","year":"2021","journal-title":"J Interv Cardiol"},{"issue":"10278","key":"10.1016\/j.ejim.2024.08.010_bib0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurheartj\/ehx247","article-title":"Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up","volume":"39","author":"Schuurman","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2024.08.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006973","article-title":"Computed tomographic coronary angiography\u2013derived plaque characteristics predict major adverse cardiovascular events","volume":"11","author":"Nerlekar","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2024.08.010_bib0043","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.ejim.2024.08.010_bib0044","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med [Internet]"},{"issue":"25","key":"10.1016\/j.ejim.2024.08.010_bib0045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"New England Journal of Medicine [Internet]"},{"key":"10.1016\/j.ejim.2024.08.010_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1166762","article-title":"Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions","volume":"14","author":"Chai","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2024.08.010_bib0047","article-title":"Effect of ezetimibe-statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.ejim.2024.08.010_bib0048","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11883-022-01054-2","article-title":"Bempedoic acid: for whom and when","volume":"24","author":"Ruscica","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"15","key":"10.1016\/j.ejim.2024.08.010_bib0049","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0051","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa054699","article-title":"Effect of ACAT inhibition on the progression of coronary atherosclerosis","volume":"354","author":"Nissen","year":"2006","journal-title":"New England J Med"},{"issue":"2","key":"10.1016\/j.ejim.2024.08.010_bib0052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14779072.5.2.265","article-title":"Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability","volume":"5","author":"Johnson","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0053","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.ejim.2024.08.010_bib0054","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024754","article-title":"Antiatherosclerotic effects of CSL112 mediated by enhanced cholesterol efflux capacity","volume":"11","author":"Kingwell","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.ejim.2024.08.010_bib0055","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","article-title":"Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction","volume":"390","author":"Gibson","year":"2024","journal-title":"New England J Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0056","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9149(97)00221-X","article-title":"Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin","volume":"79","author":"Takagi","year":"1997","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.ejim.2024.08.010_bib0057","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA [Internet]"},{"issue":"1","key":"10.1016\/j.ejim.2024.08.010_bib0058","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-017-0637-0","article-title":"Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology","volume":"16","author":"Kovarnik","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.ejim.2024.08.010_bib0059","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA [Internet]"},{"issue":"22","key":"10.1016\/j.ejim.2024.08.010_bib0060","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.08.010_bib0061","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2024.08.010_bib0062","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"R\u00e4ber","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2024.08.010_bib0063","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003316","article-title":"Noninvasive imaging of atherosclerotic plaque progression: status of coronary computed tomography angiography","volume":"8","author":"Sandfort","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2024.08.010_bib0064","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jcmg.2016.04.013","article-title":"Impact of Intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study","volume":"10","author":"Shin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009750","article-title":"Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography","volume":"13","author":"Smit","year":"2020","journal-title":"Circ Cardiovasc Imag"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0066","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1536\/ihj.14-311","article-title":"Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease","volume":"56","author":"Masuda","year":"2015","journal-title":"Int Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0067","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1253\/circj.CJ-17-0598","article-title":"Effects of ezetimibe-statin combination therapy on coronary atherosclerosis in acute coronary syndrome","volume":"82","author":"Hibi","year":"2018","journal-title":"Circulation J"},{"issue":"22","key":"10.1016\/j.ejim.2024.08.010_bib0068","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejim.2024.08.010_bib0069","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imag"},{"issue":"18","key":"10.1016\/j.ejim.2024.08.010_bib0070","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0071","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0072","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2024.08.010_bib0073","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jacc.2019.07.062","article-title":"From detecting the vulnerable plaque to managing the vulnerable patient: JACC State-of-the-Art Review","volume":"74","author":"Arbab-Zadeh","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2024.08.010_bib0074","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jcmg.2012.07.007","article-title":"Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions","volume":"5","author":"Fleg","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ejim.2024.08.010_bib0075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.ejim.2024.08.010_bib0076","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2024.08.010_bib0077","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005543","article-title":"Coronary atherosclerotic vulnerable plaque: current perspectives","volume":"6","author":"Stefanadis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2024.08.010_bib0078","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2019.03.005","article-title":"Coronary atheroma regression and adverse cardiac events: a systematic review and meta-regression analysis","volume":"284","author":"Bhindi","year":"2019","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.ejim.2024.08.010_bib0079","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2010.02.026","article-title":"Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome","volume":"55","author":"Nicholls","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ejim.2024.08.010_bib0080","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jacc.2023.08.019","article-title":"Concomitant coronary atheroma regression and stabilization in response to lipid-lowering therapy","volume":"82","author":"Biccir\u00e8","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T01:37:06Z","timestamp":1730597826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524003480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":80,"alternative-id":["S0953620524003480"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.08.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical relevance of the reversal of coronary atherosclerotic plaque","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}